Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-31 @ 12:02 PM
Study NCT ID:
NCT01512758
Status:
COMPLETED
Last Update Posted:
2019-03-15
First Post:
2012-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2013-10-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-13
First Submit QC Date:
None
Study First Post Date:
2012-01-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-09
Results First Submit QC Date:
None
Results First Post Date:
2019-03-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-29
Last Update Post Date:
2019-03-15
Last Update Post Date Type:
ACTUAL